|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 84, 148-153, Copyright © 1983 by American College of Chest Physicians
ARTICLES |
AF Gelb, RB Dreisen, JD Epstein, JD Silverthorne, Y Bickel, M Fields, WA Border and CR Taylor
We obtained results of lung immune complexes (LIC), circulating immune complexes (CIC), 48-hour gallium lung scans (scans), bronchoalveolar lavage (BAL), and pulmonary function tests in 20 patients with idiopathic interstitial pneumonitis-fibrosis. Sixteen patients had predominantly interstitial (13 cases UIP) and/or intraalveolar (3 cases DIP) cellular disease (group 1). Prior to corticosteroid therapy in group 1, scans were positive in 75 percent, CIC were elevated in 86 percent, LIC were present in 64 percent, and BAL was abnormal in 90 percent. Duration of follow-up after treatment was 3.5 +/- 1.0 year. In group 1 after treatment with corticosteroids in 13 patients and corticosteroids and penicillamine (three patients) and plasmapheresis (one patient), only four patients remain stable or improved. After corticosteroid therapy, elevated CIC returned to normal values despite progressive patient deterioration. In three patients, lung immune complexes were still detected after circulating immune complexes had returned to normal after corticosteroid therapy. In group 2 were four patients with fibrotic disease; scans and CIC were uniformly negative, LIC were weakly present in only one patient, and BAL was abnormal in all. Despite corticosteroid therapy, all have died or deteriorated. These results suggest that positive gallium lung scans, BAL, circulating immune complexes, and to a lesser extent, lung immune complexes are associated with the cellular phase of interstitial pneumonia, but do not reliably identify a corticosteroid-responsive group.
This article has been cited by other articles:
![]() |
S. P. Hart, K. M. Alexander, and I. Dransfield Immune Complexes Bind Preferentially to Fc{gamma}RIIA (CD32) on Apoptotic Neutrophils, Leading to Augmented Phagocytosis by Macrophages and Release of Proinflammatory Cytokines J. Immunol., February 1, 2004; 172(3): 1882 - 1887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Nicholson, L. G. Fulford, T. V. Colby, R. M. du Bois, D. M. Hansell, and A. U. Wells The Relationship between Individual Histologic Features and Disease Progression in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 173 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishizaka, N. Hasegawa, K. Nakamura, Y. Takagi, M. Takano, K. Yamaguchi, and A. Kubo Usefulness of Pulmonary Vascular Leakiness Assessment in Interstitial Pneumonitis Chest, May 1, 2001; 119(5): 1455 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. A. KATZENSTEIN and J. L. MYERS Idiopathic Pulmonary Fibrosis . Clinical Relevance of Pathologic Classification Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1301 - 1315. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |